Lancaster JM - Search Results

1

Gedunin, a novel natural substance, inhibits ovarian cancer cell proliferation.

Kamath SG, Chen N, Xiong Y, Wenham R, Apte S, Humphrey M, Cragun J, Lancaster JM. Kamath SG, et al. Among authors: lancaster jm. Int J Gynecol Cancer. 2009 Dec;19(9):1564-9. doi: 10.1111/IGC.0b013e3181a83135. Int J Gynecol Cancer. 2009. PMID: 19955938

2

Molecular aspects of ovarian cancer.

Wenham RM, Lancaster JM, Berchuck A. Wenham RM, et al. Among authors: lancaster jm. Best Pract Res Clin Obstet Gynaecol. 2002 Aug;16(4):483-97. doi: 10.1053/beog.2002.0298. Best Pract Res Clin Obstet Gynaecol. 2002. PMID: 12413930 Review.

3

High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival.

Lancaster JM, Sayer R, Blanchette C, Calingaert B, Whitaker R, Schildkraut J, Marks J, Berchuck A. Lancaster JM, et al. Clin Cancer Res. 2003 Feb;9(2):762-6. Clin Cancer Res. 2003. PMID: 12576447

4

No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.

Lancaster JM, Wenham RM, Halabi S, Calingaert B, Marks JR, Moorman PG, Bentley RC, Berchuck A, Schildkraut JM. Lancaster JM, et al. Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):226-7. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12646513 No abstract available.

5

Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer.

Wenham RM, Calingaert B, Ali S, McClean K, Whitaker R, Bentley R, Lancaster JM, Schildkraut J, Marks J, Berchuck A. Wenham RM, et al. Among authors: lancaster jm. J Soc Gynecol Investig. 2003 Sep;10(6):381-7. doi: 10.1016/s1071-5576(03)00141-2. J Soc Gynecol Investig. 2003. PMID: 12969782

6

High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels.

Lancaster JM, Sayer RA, Blanchette C, Calingaert B, Konidari I, Gray J, Schildkraut J, Schomberg DW, Marks JR, Berchuck A. Lancaster JM, et al. Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1529-35. doi: 10.1111/j.1525-1438.2006.00623.x. Int J Gynecol Cancer. 2006. PMID: 16884361

7

Identification of genes associated with ovarian cancer metastasis using microarray expression analysis.

Lancaster JM, Dressman HK, Clarke JP, Sayer RA, Martino MA, Cragun JM, Henriott AH, Gray J, Sutphen R, Elahi A, Whitaker RS, West M, Marks JR, Nevins JR, Berchuck A. Lancaster JM, et al. Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1733-45. doi: 10.1111/j.1525-1438.2006.00660.x. Int J Gynecol Cancer. 2006. PMID: 17009964

8

Genomic signatures to guide the use of chemotherapeutics.

Potti A, Dressman HK, Bild A, Riedel RF, Chan G, Sayer R, Cragun J, Cottrill H, Kelley MJ, Petersen R, Harpole D, Marks J, Berchuck A, Ginsburg GS, Febbo P, Lancaster J, Nevins JR. Potti A, et al. Nat Med. 2006 Nov;12(11):1294-300. doi: 10.1038/nm1491. Epub 2006 Oct 22. Nat Med. 2006. PMID: 17057710 Retracted.

9

Integration of clinical information and gene expression profiles for prediction of chemo-response for ovarian cancer.

Li L, Chen L, Goldgof D, George F, Chen Z, Rao A, Cragun J, Sutphen R, Lancaster J. Li L, et al. Conf Proc IEEE Eng Med Biol Soc. 2005;2005:4818-21. doi: 10.1109/IEMBS.2005.1615550. Conf Proc IEEE Eng Med Biol Soc. 2005. PMID: 17281320

10

Improving Reliability of Response Prediction to Platinum-Based Therapy by AdaBoost and Multiple Classifiers.

Chen L, Li L, Goldgof D, George F, Chen Z, Rao A, Cragun J, Sutphen R, Lancaster J. Chen L, et al. Conf Proc IEEE Eng Med Biol Soc. 2005;2005:4822-5. doi: 10.1109/IEMBS.2005.1615551. Conf Proc IEEE Eng Med Biol Soc. 2005. PMID: 17281321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page